Digihost Technology
DGHI
Bakkt Holdings
BKKT
BIT Mining
BTCM
The9 Ltd
NCTY
Hut 8
HUT
US Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies
- 0.566
- +0.049+9.50%
Trading Jan 16 12:37 ET
17.58MMarket Cap-0.76P/E (TTM)
0.590High0.500Low756.31KVolume0.511Open0.517Pre Close413.74KTurnover2.82%Turnover RatioLossP/E (Static)31.06MShares2.60052wk High0.77P/B15.17MFloat Cap0.32552wk Low--Dividend TTM26.81MShs Float33.340Historical High--Div YieldTTM17.40%Amplitude0.325Historical Low0.547Avg Price1Lot Size
ImmunoPrecise Antibodies Key Stats
EPS
According to the latest financial report of ImmunoPrecise Antibodies, the latest earnings per share (TTM) for the company is -0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CAD
Quarterly
Loading...
FCF
Interested in knowing about ImmunoPrecise Antibodies's free cash flow? The latest report shows it as -2.31M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CAD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ImmunoPrecise Antibodies shows that the company's current ratio is 1.01, indicating healthy liquidity.
Currency: CAD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ImmunoPrecise Antibodies, the quick ratio is 0.71, indicating that the company can meet its short-term debt obligations.
Currency: CAD
Quarterly
Loading...
ROE
Want to learn more about the financial health of ImmunoPrecise Antibodies? The latest ROE figure is -7.79%, indicating that the company has stable profitability.
Currency: CAD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ImmunoPrecise Antibodies, the total asset return on investment (ROA) is -4.28%.
Currency: CAD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ImmunoPrecise Antibodies's latest financial report to see how their gross margin is doing - currently at 56.11%.
Currency: CAD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ImmunoPrecise Antibodies, the net profit margin is -41.68%, which is a good sign for its profitability.
Currency: CAD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
